CEL-SCI CORPORATION Operating Leases, Future Minimum Payments Due, Next Twelve Months
CEL-SCI CORPORATION (CVM) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $163.00 thousand as of 2019-12-31, per its 10-Q/A filed 2020-12-30.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-12-30
- 2019-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $163.00K.
- 2019-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $238.00K.
- 2019-03-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $238.00K.
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $238.00K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months | Operating Leases, Future Minimum Payments Due, Next Twelve Months as first filed |
|---|---|---|
| 2019-12-31 | $163.00K 10-Q/A · filed 2020-12-30 | |
| 2019-06-30 | $238.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $238.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $238.00K 10-Q · filed 2019-02-14 | |
| 2018-06-30 | $258.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $258.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $258.00K 10-Q · filed 2018-02-12 | |
| 2017-06-30 | $251.00K 10-Q/A · filed 2017-12-11 | $2.00M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $251.00K 10-Q/A · filed 2017-12-11 | |
| 2016-12-31 | $251.00K 10-Q/A · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |